Hori; Nobuaki

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hori; Nobuaki.The latest application filed is for "human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof".

Company Profile

0.9.11

Hori; Nobuaki - Kanagawa JP
HORI; Nobuaki - Yokohama-shi JP
Hori; Nobuaki - Yokohama JP
Hori, Nobuaki - Kawasaki-shi JP
Hori, Nobuaki - Hanagawa JP
Hori; Nobuaki - Kawasaki JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Human Monoclonal Antibody Against A Costimulatory Signal Transduction Molecule Ailim And Pharmaceutical Use Thereof App 20120039874 - Tsuji; Takashi ; et al.	2012-02-16
Methods of treating systemic lupus erythematosus with an antibody against costimulatory signal transduction molecule ailim Grant 7,988,965 - Tsuji , et al. August 2, 2	2011-08-02
Oxygen-carrying Blood Substitute Preparations App 20100145298 - HORI; Nobuaki ; et al.	2010-06-10
Production of a multimeric protein by cell fusion method Grant 7,429,380 - Hori , et al. September 30, 2	2008-09-30
Human Monoclonal Antibody Against A Costimulatory Signal Transduction Molecule Ailim And Pharmaceutical Use Thereof App 20080199466 - Tsuji; Takashi ; et al.	2008-08-21
Oxygen-carrying Blood Substitute Preparations App 20080193516 - HORI; Nobuaki ; et al.	2008-08-14
Methods of treating an inflammatory disorder and prohibiting proliferation, cytokine production, and signal transduction with antibody against costimulatory signal transduction molecule AILIM Grant 7,166,283 - Tsuji , et al. January 23, 2	2007-01-23
Human monoclonal antibody against a costimulatory signal transduction molecule AILIM Grant 6,803,039 - Tsuji , et al. October 12, 2	2004-10-12
Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof App 20040180052 - Tsuji, Takashi ; et al.	2004-09-16
Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof App 20040146991 - Tsuji, Takashi ; et al.	2004-07-29
Production of a multimeric protein by cell fusion method App 20040142430 - Hori, Nobuaki ; et al.	2004-07-22
Production of a multimeric protein by cell fusion method Grant 6,677,138 - Hori , et al. January 13, 2	2004-01-13
Production of a multimeric protein by cell fusion method App 20030022291 - Hori, Nobuaki ; et al.	2003-01-30
Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof App 20020102658 - Tsuji, Takashi ; et al.	2002-08-01
Production Of Multimeric Protein By Cell Fusion Method App 20020098551 - Hori, Nobuaki ; et al.	2002-07-25
Production of multimeric protein by cell fusion method Grant 6,420,140 - Hori , et al. July 16, 2	2002-07-16
Production of a multimeric protein by cell fusion method App 20020076763 - Hori, Nobuaki ; et al.	2002-06-20
Production of a multimeric protein by cell fusion method Grant 6,207,418 - Hori , et al. March 27, 2	2001-03-27
Production of a multimeric protein by cell fusion method Grant 5,916,771 - Hori , et al. June 29, 1	1999-06-29
Pump with back suction phase Grant 5,549,223 - Hori August 27, 1	1996-08-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.